$CURR News : CURE Pharmaceutical Augments Its Ex
Post# of 103016
$CURR News : CURE Pharmaceutical Augments Its Existing U.S. DEA License in Order to Initiate Development of Its Psychedelics-Based Pharmaceutical Clinical Pipeline
https://www.barchart.com/story/news/1365570/c...l-pipeline